Inqovi

A combination of decitabine and cedazuridine used to treat adults with certain types of myelodysplastic syndromes, including chronic myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. Decitabine stops cells from making DNA, which may help keep cancer cells from growing and may kill them. Cedazuridine prevents the breakdown of decitabine in the body, which may allow more cancer cells to be killed. Inqovi is a type of antimetabolite and a type of cytidine deaminase inhibitor. Also called decitabine and cedazuridine.